Lipogenesis in cancer progression (review)

International Journal of Oncology

Volumn 45, Issue 2, 2014, Pages 485-492

  Mounier, Catherine ^a   Bouraoui, Lamia ^a   Rassart, Eric ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Epithelial to mesenchymal transition; Fatty acid synthase; Lipogenesis; Metastasis; Stearoyl coa desaturase 1

Indexed keywords

ACYL COENZYME A DESATURASE 1; FATTY ACID SYNTHASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

APOPTOSIS; CANCER CELL; CANCER GROWTH; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LIPOGENESIS; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; DISEASE COURSE; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LIPOGENESIS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84902584099     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2441     Document Type: Review

References (102)

1. Medes G, Thomas A and Weinhouse S: Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 13: 27-29, 1953.
2. Swinnen JV, Brusselmans K and Verhoeven G: Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 9: 358-365, 2006. (Pubitemid 44101970)
3. Postic C and Girard J: The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 34: 643-648, 2008.
4. Ntambi JM: The regulation of stearoyl-CoA desaturase (SCD). Prog Lipid Res 34: 139-150, 1995.
5. Neuschwander-Tetri BA: Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52: 774-788, 2010.
6. Viollet B, Guigas B, Leclerc J, et al: AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol (Oxf) 196: 81-98, 2009.
7. Viollet B, Foretz M, Guigas B, et al: Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 574: 41-53, 2006. (Pubitemid 43905795)
8. Kuhajda FP: Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16: 202-208, 2000.
9. Bougnoux P, Chajes V, Lanson M, et al: Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma. Breast Cancer Res Treat 20: 185-194, 1992.
10. Guo D, Reinitz F, Youssef M, et al: An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov 1: 442-456, 2011.
11. Nieva C, Marro M, Santana-Codina N, Rao S, Petrov D and Sierra A: The lipid phenotype of breast cancer cells characterized by Raman microspectroscopy: towards a stratification of malignancy. PLoS One 7: e46456, 2012.
12. Pizer ES, Chrest FJ, DiGiuseppe JA and Han WF: Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 58: 4611-4615, 1998. (Pubitemid 28480625)
13. Horiguchi A, Asano T, Asano T, Ito K, Sumitomo M and Hayakawa M: Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells. J Urol 180: 729-736, 2008.
14. Ma J, Yan R, Zu X, et al: Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J Biol Chem 283: 3418-3423, 2008.
15. Chajes V, Cambot M, Moreau K, Lenoir GM and Joulin V: Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res 66: 5287-5294, 2006. (Pubitemid 43844953)
16. Brusselmans K, De Schrijver E, Verhoeven G and Swinnen JV: RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res 65: 6719-6725, 2005. (Pubitemid 41060709)
17. Zhan Y, Ginanni N, Tota MR, et al: Control of cell growth and survival by enzymes of the fatty acid synthesis pathway in HCT-116 colon cancer cells. Clin Cancer Res 14: 5735-5742, 2008.
18. Scaglia N, Caviglia JM and Igal RA: High stearoyl-CoA desaturase protein and activity levels in simian virus 40 transformed-human lung fibroblasts. Biochim Biophys Acta 1687: 141-151, 2005. (Pubitemid 40228994)
19. Scaglia N, Chisholm JW and Igal RA: Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PloS One 4: e6812, 2009.
20. Scaglia N and Igal RA: Inhibition of stearoyl-CoA desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. Int J Oncol 33: 839-850, 2008.
21. Morgan-Lappe SE, Tucker LA, Huang X, et al: Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen. Cancer Res 67: 4390-4398, 2007. (Pubitemid 46815088)
22. Guo D, Prins RM, Dang J, et al: EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal 2: ra82, 2009.
23. Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK and Koay ES: Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics 4: 1686-1696, 2005. (Pubitemid 41749262)
24. Porstmann T, Griffiths B, Chung YL, et al: PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24: 6465-6481, 2005. (Pubitemid 41486630)
25. Wang HQ, Altomare DA, Skele KL, et al: Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene 24: 3574-3582, 2005. (Pubitemid 40756227)
26. Bandyopadhyay S, Pai SK, Watabe M, et al: FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis. Oncogene 24: 5389-5395, 2005. (Pubitemid 43080109)
27. Chang Y, Wang J, Lu X, Thewke DP and Mason RJ: KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells. J Lipid Res 46: 2624-2635, 2005. (Pubitemid 43107474)
28. Swinnen JV, Beckers A, Brusselmans K, et al: Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype. Cancer Res 65: 2441-2448, 2005. (Pubitemid 40490156)
29. Mehes G, Witt A, Kubista E and Ambros PF: Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159: 17-20, 2001. (Pubitemid 33704186)
30. Iwatsuki M, Mimori K, Yokobori T, et al: Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101: 293-299, 2010.
31. Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273, 2009.
32. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
33. Voulgari A and Pintzas A: Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 1796: 75-90, 2009.
34. Yang J, Mani SA, Donaher JL, et al: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939, 2004. (Pubitemid 38798858)
35. Batlle E, Sancho E, Franci C, et al: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
36. Darnell JE Jr: Transcription factors as targets for cancer therapy. Nature reviews. Cancer 2: 740-749, 2002.
37. Moustakas A and Heldin CH: Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520, 2007. (Pubitemid 47308444)
38. Blobe GC, Schiemann WP and Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358, 2000. (Pubitemid 30408720)
39. Stambolic V and Woodgett JR: Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303: 701-704, 1994. (Pubitemid 24325998)
40. Peinado H, Portillo F and Cano A: Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 48: 365-375, 2004. (Pubitemid 39360388)
41. Hamada F and Bienz M: The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. Dev Cell 7: 677-685, 2004. (Pubitemid 39462688)
42. He TC, Sparks AB, Rago C, et al: Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512, 1998. (Pubitemid 28425575)
43. Takeichi M, Nakagawa S, Aono S, Usui T and Uemura T: Patterning of cell assemblies regulated by adhesion receptors of the cadherin superfamily. Philos Trans R Soc Lond B Biol Sci 355: 885-890, 2000. (Pubitemid 30613313)
44. Efstathiou JA and Pignatelli M: Modulation of epithelial cell adhesion in gastrointestinal homeostasis. Am J Pathol 153: 341-347, 1998. (Pubitemid 28373644)
45. Wijnhoven BP and Pignatelli M: E-cadherin-catenin: more than a 'sticky' molecular complex. Lancet 354: 356-357, 1999. (Pubitemid 29355748)
46. Gilles C, Polette M, Mestdagt M, et al: Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 63: 2658-2664, 2003. (Pubitemid 36605210)
47. Takahashi M, Tsunoda T, Seiki M, Nakamura Y and Furukawa Y: Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene 21: 5861-5867, 2002. (Pubitemid 35007236)
48. Rakha EA: Pitfalls in outcome prediction of breast cancer. J Clin Pathol 66: 458-464, 2013.
49. Milgraum LZ, Witters LA, Pasternack GR and Kuhajda FP: Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 3: 2115-2120, 1997. (Pubitemid 27505140)
50. Epstein JI, Carmichael M and Partin AW: OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology 45: 81-86, 1995.
51. Lupu R and Menendez JA: Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators? Endocrinology 147: 4056-4066, 2006. (Pubitemid 44274975)
52. Davidson B, Smith Y, Nesland JM, Kaern J, Reich R and Trope CG: Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion. Hum Pathol 44: 2449-2460, 2013.
53. Pflug BR, Pecher SM, Brink AW, Nelson JB and Foster BA: Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model. Prostate 57: 245-254, 2003. (Pubitemid 37267807)
54. Greenberg NM, DeMayo F, Finegold MJ, et al: Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92: 3439-3443, 1995.
55. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G, et al: Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst 101: 519-532, 2009.
56. Swinnen JV, Esquenet M, Goossens K, Heyns W and Verhoeven G: Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res 57: 1086-1090, 1997. (Pubitemid 27138606)
57. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G and Swinnen JV: Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 15: 1817-1828, 2001. (Pubitemid 32939311)
58. Van de Sande T, De Schrijver E, Heyns W, Verhoeven G and Swinnen JV: Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res 62: 642-646, 2002. (Pubitemid 34126933)
59. Graner E, Tang D, Rossi S, et al: The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 5: 253-261, 2004. (Pubitemid 38402117)
60. Selvendiran K, Ahmed S, Dayton A, et al: HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase. Mol Cancer Res 8: 1188-1197, 2010.
61. Hsu YC and Liou YM: The anti-cancer effects of (-)-epigal-locatechin-3- gallate on the signaling pathways associated with membrane receptors in MCF-7 cells. J Cell Physiol 226: 2721-2730, 2011.
62. Menendez JA, Vellon L, Mehmi I, et al: Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc Natl Acad Sci USA 101: 10715-10720, 2004. (Pubitemid 38955808)
63. Hartkopf AD, Banys M and Fehm T: HER2-positive DTCs/CTCs in breast cancer. Recent Results Cancer Res 195: 203-215, 2012.
64. Lee JS, Yoon IS, Lee MS, et al: Anticancer activity of pristimerin in epidermal growth factor receptor 2-positive SKBR3 human breast cancer cells. Biol Pharm Bull 36: 316-325, 2013.
65. Swinnen JV, Heemers H, Deboel L, Foufelle F, Heyns W and Verhoeven G: Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene 19: 5173-5181, 2000.
66. Oskouian B: Overexpression of fatty acid synthase in SKBR3 breast cancer cell line is mediated via a transcriptional mechanism. Cancer Lett 149: 43-51, 2000.
67. Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP and Chinnaiyan AM: Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 63: 132-139, 2003. (Pubitemid 36070431)
68. Nicolini A, Giardino R, Carpi A, et al: Metastatic breast cancer: an updating. Biomed Pharmacother 60: 548-556, 2006.
69. Camassei FD, Cozza R, Acquaviva A, et al: Expression of the lipogenic enzyme fatty acid synthase (FAS) in retinoblastoma and its correlation with tumor aggressiveness. Invest Ophthalmol Vis Sci 44: 2399-2403, 2003. (Pubitemid 36618394)
70. Rashid A, Pizer ES, Moga M, et al: Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 150: 201-208, 1997. (Pubitemid 27027110)
71. Kalyankrishna S and Grandis JR: Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 24: 2666-2672, 2006. (Pubitemid 46622088)
72. Qiu Z, Huang C, Sun J, et al: RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells. Cancer Sci 98: 1099-1106, 2007. (Pubitemid 46865397)
73. Horiguchi A, Asano T, Asano T, Ito K, Sumitomo M and Hayakawa M: Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma. J Urol 180: 1137-1140, 2008.
74. Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, Heimburger DC, et al: The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 31: 1068-1073, 2000.
75. Carvalho MA, Zecchin KG, Seguin F, et al: Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int J Cancer 123: 2557-2565, 2008.
76. Murata S, Yanagisawa K, Fukunaga K, et al: Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice. Cancer Sci 101: 1861-1865, 2010.
77. Zaytseva YY, Rychahou PG, Gulhati P, et al: Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer. Cancer Res 72: 1504-1517, 2012.
78. Chajes V, Hulten K, Van Kappel AL, et al: Fatty-acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden. Int J Cancer 83: 585-590, 1999. (Pubitemid 29508033)
79. Chajes V, Thiebaut AC, Rotival M, et al: Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC study. Am J Epidemiol 167: 1312-1320, 2008. (Pubitemid 351770558)
80. Pala V, Krogh V, Muti P, et al: Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst 93: 1088-1095, 2001. (Pubitemid 32717541)
81. Mauvoisin D, Charfi C, Lounis AM, Rassart E and Mounier C: Decreasing stearoyl-CoA desaturase-1 expression inhibits beta-catenin signaling in breast cancer cells. Cancer Sci 104: 36-42, 2013.
82. Goodridge AG: Regulation of the activity of acetyl coenzyme A carboxylase by palmitoyl coenzyme A and citrate. J Biol Chem 247: 6946-6952, 1972.
83. Zureik M, Ducimetiere P, Warnet JM and Orssaud G: Fatty acid proportions in cholesterol esters and risk of premature death from cancer in middle aged French men. BMJ 311: 1251-1254, 1995.
84. Petrek JA, Hudgins LC, Ho M, Bajorunas DR and Hirsch J: Fatty acid composition of adipose tissue, an indication of dietary fatty acids, and breast cancer prognosis. J Clin Oncol 15: 1377-1384, 1997. (Pubitemid 27167369)
85. Zhu ZR, Agren J, Mannisto S, et al: Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease. Nutr Cancer 24: 151-160, 1995.
86. Simonsen NR, Fernandez-Crehuet Navajas J, Martin-Moreno JM, et al: Tissue stores of individual monounsaturated fatty acids and breast cancer: the EURAMIC study. European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Am J Clin Nutr 68: 134-141, 1998.
87. Lamouille S and Derynck R: Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-beta-induced epithelial-mesenchymal transition. Cells Tissues Organs 193: 8-22, 2011.
88. Lin SY, Xia W, Wang JC, et al: Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97: 4262-4266, 2000. (Pubitemid 30226121)
89. Rios-Esteves J and Resh MD: Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins. Cell Rep 4: 1072-1081, 2013.
90. Samuel W, Nagineni CN, Kutty RK, et al: Transforming growth factor-beta regulates stearoyl coenzyme A desaturase expression through a Smad signaling pathway. J Biol Chem 277: 59-66, 2002. (Pubitemid 34952028)
91. McIntyre E, Blackburn E, Brown PJ, Johnson CG and Gullick WJ: The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer. Breast Cancer Res Treat 122: 105-110, 2010.
92. Menendez JA, Vazquez-Martin A, Ropero S, Colomer R and Lupu R: HER2 (erbB-2)-targeted effects of the omega-3 polyunsaturated fatty acid, alpha-linolenic acid (ALA; 18:3n-3), in breast cancer cells: the 'fat features' of the 'Mediterranean diet' as an 'anti-HER2 cocktail'. Clin Transl Oncol 8: 812-820, 2006.
93. Wells WA, Schwartz GN, Morganelli PM, Cole BF, Gibson JJ and Kinlaw WB: Expression of 'Spot 14' (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker. Breast Cancer Res Treat 98: 231-240, 2006. (Pubitemid 44050774)
94. Kinlaw WB, Quinn JL, Wells WA, Roser-Jones C and Moncur JT: Spot 14: A marker of aggressive breast cancer and a potential therapeutic target. Endocrinology 147: 4048-4055, 2006. (Pubitemid 44268359)
95. Chin K, DeVries S, Fridlyand J, et al: Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541, 2006. (Pubitemid 44854748)
96. Moreau K, Dizin E, Ray H, et al: BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase. J Biol Chem 281: 3172-3181, 2006. (Pubitemid 43845927)
97. Saxena NK and Sharma D: Metastasis suppression by adiponectin: LKB1 rises up to the challenge. Cell Adh Migr 4: 358-362, 2010.
98. Scott KE, Wheeler FB, Davis AL, Thomas MJ, Ntambi JM, Seals DF, et al: Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis. PloS One 7: e29761, 2012.
99. Menendez JA and Lupu R: Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9). Curr Pharm Biotechnol 7: 495-502, 2006. (Pubitemid 46017541)
100. Swinnen JV, Ulrix W, Heyns W and Verhoeven G: Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci USA 94: 12975-12980, 1997. (Pubitemid 27518461)
101. Huang WC, Li X, Liu J, Lin J and Chung LW: Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol Cancer Res 10: 133-142, 2012.
102. Bhandary B, Marahatta A, Kim HR and Chae HJ: Mitochondria in relation to cancer metastasis. J Bioenerg Biomembr 44: 623-627, 2012.